The results suggested that GSTP1 promoter methylation is higher in cancer tissue than in benign tissue from the same individual and reduced GSTP1 expression is observed in prostate cancer specimens compared to their benign counterparts. The gene discussed is GSTP1; the disease is prostate carcinoma.